Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, January 25, 2012

Joslin to build new diabetes research center with $10.8M support

By Michelle Lang

The Massachusetts Life Sciences Center awarded a $5 million grant to the Joslin Diabetes Center, which said it plans to match the grant, bringing in a total of $10.8 million to build the Translational Center for the Cure of Diabetes in Boston’s Longwood Medical area.

Joslin Diabetes Center, a teaching and research-affiliated hospital of Harvard Medical School, said in a news release that donations will make up the matching support of the MLSC grant. The new center is expected to create about 50 new life sciences jobs.

The new center, a renovation of 20,000 square feet of space, will house labs and translational study platforms for both Type 1 and Type 2 diabetes and prevention of the disease and of obesity, Joslin chief scientific officer Dr. George King said in a statement. It will also include 15 sub-projects covering clinical research, clinical care and basic research with translational diabetes programs.

 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

How will Chinese investment in U.S. cleantech companies affect the U.S. cleantech space?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.